Drugs manufacturer rewarded for commitment to become a leading global Halal pharmaceutical provider

By Lee Min Keong

Pharmaniaga Manufacturing Bhd (PMB), one of Malaysia’s leading drugs manufacturers, won the Excellence in Pharmaceutical award at the the inaugural Global Halal Excellence Awards (GHEA) 2020 recently. 

The halal awards recognise leaders and organisations globally who have performed and contributed to growing the global Halal economy, and highlights the importance of the Halal brand and businesses in the global market. 

GHEA 2020 is organised by Asia Pacific Business Council for Sustainability and The Leadership Post, which also held the Global Business Leadership Award (GBLA) 2020 at the same time.

A wholly-owned subsidiary of Bursa Malaysia-listed Pharmaniaga Bhd, PMB offers a wide range of products for the pharmaceutical industry.

The award it received is apt reward for PMB’s commitment is to become a leading global Halal pharmaceutical provider. To achieve this goal, PMB has received the Halal certification from Jabatan Kemajuan Islam Malaysia (JAKIM) for more than 70 products to-date and is set to attain the certification for a further 10 products in 2020. 

Focus on Halal certification

A company spokesperson says PMB has collaborated with the Department of Standards Malaysia to enhance the Malaysia Halal standards and has also participated as a committee member in various Halal seminars.

“PMB’s focus will continue to be on Halal certifications of our pharmaceutical products, and also to be working together with the Halal Development Corporation to develop and enhance PMB’s suppliers on Halal and Quality programmes. 

“We will continue to strive for the growth of Halal, Malaysian-made products in the global arena,” the spokesperson reiterates.

Based on the ‘State of the Global Islamic Economy Report 2018/19’, Muslims globally spent US$87 bil (RM361 bil) on Halal pharmaceuticals in 2017, and this is forecasted to reach US$131 bil by 2023. 

The steady growth of demand for Halal pharmaceutical products is sparked by the assurance that they are clean and safe for consumption in line with Islamic requirements, and meet all the required manufacturing standards, the spokesperson explains.

 “A likewise trend is seen in Malaysia as the demand for Halal pharmaceutical products continue to rise, in line with increasing awareness on the benefits and importance of consuming Halal products, especially amongst the local Muslim population,” he adds.

Leading generic drug manufacturer

Pharmaniaga is one of the major generic drug manufacturers in Malaysia and as a group, it has a total of nine plants at seven sites, including PMB. At the backbone of the operations is its in-house Research & Development Centre with almost 100 highly trained researchers and formulators who work on generic drugs to manufacture.

It has more than 150 products under its portfolio, comprising oral solid dosages, liquid cream, ointments, capsule powder (sterile and non-sterile) and granules. PMB manufactures general pharmaceuticals, cephalosporin and over-the-counter (OTC) products, including supplements and vitamins.

Its facilities are designed and constructed in accordance to international pharmaceutical engineering guidelines and in compliance with the Pharmaceutical Inspection Co-operation Scheme (PICS/S) for Good Manufacturing Practice (GMP) of pharmaceuticals.

Its Quality Management System is certified to ISO 9001 standards, its Occupational Health and Safety practices are certified to OHSAS 18001 standards whilst its Environment Management System is certified to ISO 14001 standards. Its Quality Control Laboratories are ISO/IEC 17025 accredited. 

Compliance to these quality systems has made PMB the preferred contract-manufacturing partner for multinational companies, the spokesperson says.

“Supported by more than 400 strong professionals from various fields, PMB has the capacity, capability and commitment to deliver high quality, Halal-compliant products and services to cater to the nation’s healthcare needs.”